Metenolone Acetate, also written as Methenolone Acetate, is a synthetic steroid ester identified by CAS Number 434-05-9. It has the molecular formula C₂₂H₃₂O₃ and a molecular weight of approximately 344.5 g/mol. The compound is the acetate ester of metenolone and belongs to the androgenic and anabolic steroid category.
The Nova Techsciences compound page should present Metenolone Acetate through accurate chemical identification, verifiable documentation and balanced safety information. It should not be presented as a nutritional supplement or promoted for unsupervised physique, sporting or hormone-related use.
Metenolone Acetate Overview
Important compound information includes:
- Compound name: Metenolone Acetate
- Alternative spelling: Methenolone Acetate
- CAS Number: 434-05-9
- Molecular formula: C₂₂H₃₂O₃
- Molecular weight: Approximately 344.5 g/mol
- Compound category: Androgen and anabolic steroid ester
- Associated Nova Techsciences product: PRIMONOVA
Metenolone Acetate should be distinguished from Metenolone Enanthate. Although both are derived from the same active steroidal structure, the attached ester is different, resulting in separate chemical identifiers and technical specifications. Product labels, compound pages, Certificates of Analysis and structured data should therefore use the correct compound name and CAS number.
Quality Documentation and Traceability
A reliable compound profile should be supported by appropriate analytical records. These may include raw-material identification, assay testing, impurity analysis, reference-standard comparison, stability data and batch-specific documentation.
Every batch should carry a unique identification number linked to its manufacturing and laboratory-release history. Claims concerning purity, pharmaceutical grade or manufacturing standards should only be published when supported by current evidence.
For audiences in the United Kingdom, Netherlands and other European markets, Nova Techsciences should clearly disclose the compound’s regulatory status, responsible organisation and intended-use limitations. Metenolone is prohibited at all times in competitive sport under the anabolic-agent category.
Safety Considerations
Metenolone Acetate is an anabolic-androgenic substance. Compounds in this category may affect hormonal balance, reproductive health, cholesterol, cardiovascular function, mood and other body systems. It should not be promoted for self-medication, use by minors or unsupervised performance enhancement.
Related Nova Techsciences Compounds
Methyldrostanolone
Methyldrostanolone, also known as Methasterone, is an anabolic-androgenic compound identified by CAS Number 3381-88-2. It is chemically distinct from Metenolone Acetate and requires separate regulatory information, batch documentation, contraindications and prominent liver and cardiovascular safety warnings.
Telmisartan
Telmisartan is a non-steroidal antihypertensive compound identified by CAS Number 144701-48-4. It is chemically unrelated to Metenolone Acetate and is associated with blood-pressure management in authorised medical settings. Its page should address pregnancy restrictions, kidney monitoring, interactions and prescription status.
Chlorodehydromethyltestosterone
Chlorodehydromethyltestosterone is an anabolic-androgenic steroid identified by CAS Number 2446-23-3. It has a different chemical structure from Metenolone Acetate and requires independent information covering regulatory status, liver-related risks, batch traceability and warnings against sporting or unsupervised use.
Levothyroxine Sodium T4
Levothyroxine Sodium is a synthetic thyroid-hormone compound identified by CAS Number 55-03-8. It is used in authorised thyroid-replacement settings and requires precise strength control and thyroid-function monitoring. It should not be presented for general weight loss or metabolism enhancement.
Cabergoline
Cabergoline is a dopamine D2 receptor agonist identified by CAS Number 81409-90-7. It is pharmacologically unrelated to anabolic steroids and is used in selected medically supervised prolactin-related settings. Its information should cover cardiovascular precautions, interactions and professional monitoring.
Metenolone Acetate should ultimately be presented through correct CAS identification, transparent laboratory documentation, balanced risk communication and clearly stated regulatory limitations.